Chemotherapy, Nutrition Related Cancer, Prognostic Cancer Model
Conditions
Brief summary
To compare the differences of clinical pathological, treatment and prognosis in the guided subgroups in colorectal cancer, the investigator enrolled all the colorectal cancer patients who underwent surgery and were hospitalized in the Xijing hospital.
Interventions
None listed
Sponsors
Xijing Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Inclusion criteria
* 1\. Pathologically confirmed colorectal adenocarcinoma, including hereditary colorectal cancer syndrome, such as Lynch syndrome and familial adenocarcinoma tumor polyposis, Peutz Jeghers syndrome, juvenile polyposis syndrome, and serrated polyposis syndrome; * 2\. Visit our center with complete medical records and pathological information; * 3\. Colorectal cancer patients diagnosed between 2013 and 2023.
Exclusion criteria
* 1\. The patient has other colorectal malignancies other than adenocarcinoma; * 2\. Malignant tumors adjacent to organs invading the colon and rectum; * 3\. Malignant tumors from distant organs metastasize to the colon and rectum; * 4\. Benign colorectal lesions; 5. Patients with recurrent colorectal cancer.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| overall survival | from date of diagnosis until the date of death from any cause, assessed up to 120 months | to dead or lost to follow |
| DFS | from date of diagnosis until the first documented progression or recurrence, assessed up to 120 months | disease-free survival |
Countries
China
Outcome results
None listed